· 1 Billion Nanoparticles with PDRN-Coated Exosomes
· Scalp Treatment: Specialized for promoting hair growth and preventing hair loss.
· Regenerative and Anti-Aging: High micro-RNA content induces regeneration and anti-aging effects.
· Cytokines: Promote hair growth, regulate hair growth cycle, and protect hair follicles from free radicals and stress.
· Growth Factors: Enable thicker, healthier hair growth.
· PDRN Benefits: Harnesses the body's natural healing mechanisms to promote follicle regeneration, scalp capillary production, and tissue regeneration. Used in pre-and post-hair transplant care.
· Exosome Advantage: EXO-PLUS utilizes advanced exosome technology with PDRN to deliver potent regenerative and anti-aging benefits directly to the scalp, promoting healthy hair growth and preventing loss.
· Experience the ultimate in hair rejuvenation with the power of PDRN-coated exosomes!.
NOVAMEDINTL is a specialized company that exports its products and other products through consignment R&D and consignment manufacturing.
The biggest advantage of NOVAMEDINTL's continued growth is that it is offering a variety of products to the world that meet the needs of the market using know-how that it has exported for a long time, and based on that experience, it is working on a new product development project.
The range of products exported so far is very diverse.
- Pharmaceutical.
- Medical device.
- Medical equipment.
- Cosmetics.
- Functional Cosmetics...
Our biggest strength is that we have made it competitive by enabling small amounts of OEMs and ODMs through close cooperation with consignment R&D and consignment manufacturers, facilitating support from start-up companies or companies challenging experimental new products.
In addition, it is possible to quickly launch new products into the market through the advantage of being able to quickly conduct clinical and feedback on products in connection with overseas hospitals and companies.
Currently, we are continuously selling our signature formulations by commercializing them,
and we are preparing for a new formulation.